A

Axsome Therapeutics

Biopharmaceutical company developing CNS disorder therapies

Quality Control Specialist

Regulatory & Quality (Life Sciences)Posted on Nov 10
Full-timeNew York, NY, USA

About the Job

Requirements

  • A Bachelor of Science or Bachelor of Arts degree in life science or a related field is required.
  • At least 2 years of experience in quality control or quality assurance within the pharmaceutical or biotechnology industry is required.
  • Ability to work on site Monday, Tuesday, and Thursday is required; fully remote candidates are not considered.
  • Strong understanding of data integrity in a Good Manufacturing Practice environment is required.
  • Understanding of pharmaceutical stability study design and ICH Q1 is required.
  • Ability to assess, comprehend, and analyze analytical raw data and results is required.
  • Experience with Veeva LIMS and Vault or equivalent is required.

Responsibilities

  • Compile and enter analytical release and stability data into LIMS for Certificate of Analysis and stability report generation.
  • Provide feedback on the design and workflow of the stability module in LIMS.
  • Track stability pulls, testing timelines, and reporting deadlines at contract manufacturing organizations and contract research organizations.
  • Assist with trending release and stability data.
  • Assist in preparing internal metrics presentations.
  • Support documentation and investigation of out-of-specification and out-of-trend results and laboratory investigations.
  • Contribute to authoring and reviewing quality control standard operating procedures, specifications, and technical reports.
  • Collaborate with and support quality assurance, analytical development, and other functional groups to ensure timely product release.
  • Ensure compliance with applicable Good Manufacturing Practice regulations, ICH guidelines, and standard operating procedures.

About the Company

Axsome Therapeutics

Biopharmaceutical company developing CNS disorder therapies

Axsome Therapeutics develops therapies for central nervous system disorders. Its focus is on research, development, and commercialization of treatments for conditions such as major depressive disorder, treatment-resistant depression, Alzheimer's agitation, migraine, narcolepsy, fibromyalgia, and smoking cessation. The flagship product candidate, AXS-05, is an oral NMDA receptor antagonist intended to treat MDD and TRD; it works by blocking NMDA receptors to influence brain signaling involved in mood and depression, and has received FDA Breakthrough Therapy Designation. The company earns revenue from the commercialization of its drugs, partnerships, and potential licensing deals as its pipeline progresses through clinical trials and regulatory approvals. Axsome aims to provide effective CNS therapies, advance its drug pipeline, and improve patient outcomes and quality of life.

Company size
501-1,000
Company stage
IPO
Headquarters
New York City, New York
Founded
2012

Recently Posted Jobs

Explore more opportunities at Axsome Therapeutics

See more jobs